期刊名称：EXPERT OPINION ON PHARMACOTHERAPY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Expert Opinion on Pharmacotherapy (ISSN 1465-6566) is a unique source of peer-reviewed Drug Evaluations and Reviews. Expert Opinion on Pharmacotherapy is dedicated to the systematic evaluation and review of newly approved drugs and drug classes.
Through 18 issues per year, Expert Opinion on Pharmacotherapy provides comprehensive coverage of the emerging literature on and experience with newly approved compounds and an evaluated assessment of the likely impact of these new agents on existing pharmacotherapy of specific diseases. Expert Opinion on Pharmacotherapy focuses on new drugs and drug classes from development Phase III to those that have been available to pharmacopoeia for up to 5 years.
The audience consists of research and development, regulatory and marketing decision makers in the pharmaceutical industry and decision makers in healthcare provision. Expert Opinion on Pharmacotherapy adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas. The major themes covered are as follows:
- Anti-infectives
- Cardiovascular
- Central & Peripheral Nervous Systems
- Oncologic
- Pharmacoeconomics
- Pharmacogenomics
- Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis
- Renal, Endocrine & Metabolic
Instructions to Authors
The Commissioning Editor, under the advice of the Editorial Advisory Board, solicits articles published by Ashley Publications. However, suggestions for article topics (and potential authors) are welcome, subject to final approval by the Editors and Editorial Advisory Board.
If you are interested in preparing an article, please contact the Commissioning Editor of the relevant journal with your proposal and an outline.
The following guidelines are provided to assist authors in the preparation of their manuscript
Editorial Board
Editorial Staff
Commissioning Editor: Matthew Hill
Commissioning Editor: Kristina Munn
Drug Evaluations Editor: Joanne Nicholl
Editorial Advisory Board
Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis
Kishimoto TK: Millenium Pharm., USA
Reginster J-Y: University of Liege, Belgium
Sambrook PN: Royal North Shore Hospital, Australia
Shaffer C: Inspire Pharm., USA
Stewart M: Bristol-Myers Squibb, USA
Talley NJ: Nepean Hospital, Australia
Anti-infectives
De Clercq E: Rega Institut, Belgium
Murphy R: Northwestern Univ., USA
Pozniak A: Chelsea and Westminster Hospital, UK
Snell NJC: Bayer, UK
Tarr PE: Service des Maladies Infectieuses, Switzerland
Utzinger J: Swiss Tropical Institute, Switzerland
Cardiovascular
Aziz S: University of Colorado, USA
Di Girolamo G: University of Buenos Aires, Argentina
Doggrell S: Doggrell Biomedical Communications, New Zealand
Krum H: Monash University, Australia
Ohman EM: Duke Clinical Research Institute, USA
Segal R: Merck & Co., USA
Terzic A: Mayo Clinic & Fdn, USA
Webb DJ: University of Edinburgh, UK
Wyse R: Hammersmith Hospital, UK
Renal, Endocrine & Metabolic
Diez JJ: Hospital La Paz, Spain
Di Girolamo G: University of Buenos Aires, Argentina
Fitzgerald JD: Materia Medica, UK
Khastgir J: UK
Parsons CL: Univ. of California at San Diego, USA
Patel HRH: Royal Free Hampstead NHS Trust, UK
Schellhammer PF: Eastern Virginia Medical School, USA
Stevenson J: Wynn Institute, UK
Winslow RM: Sangart, USA
Wolffenbuttel B: University Hospital Maastricht, The Netherlands
Central & Peripheral Nervous Systems
Ambrosini P: Drexel University College of Medicine, USA
Blower P: GlaxoSmithKline, UK
Findling R: Case Western Univ., USA
Goldstein JM: AstraZeneca, USA
Goodnick R: University of Miami, USA
Kasper S: University of Vienna, Austria
Kerwin R: Institute of Psychiatry, UK
Marcus D: University of Pittsburgh
Reynolds G: Queen's University Belfast, Ireland
Sommerville KW: Abbott, USA
Stahl S: University of California, USA
Pharmacoeconomics
Bennett CL: Northwestern Univ., USA
Boyle P: European Institute of Oncology, Italy
Greenberg P: Analysis Group Economics, USA
Krimsky S: Tufts University, USA
Lee K: The Chinese University of Hong Kong, China
Sculpher M: University of York, UK
Stier DM: Eureka Research, USA
Oncologic
Montemurro F: IRCC Candiolo, Italy
Patel HRH: Royal Free Hampstead NHS Trust, UK
Sikora K: Hammersmith Hospital, UK
Van Cutsem E: Univ. Hospital Gasthuisberg, Belgium
Weidle U: Roche Diagnostics, Germany
Workman P: CRC Centre for Cancer Therapeutics, UK
Pharmacogenomics
Huang S-M: Center for Drug Evaluation and Research, USA
Licinio J: Neuropsychiatric Institute, USA
Marsh S: Washington University School of Medicine, USA
Milos P: Pfizer Global Research and Development, USA
Novelli G: Univ. di Roma Tor Vergata, Italy
Pirmohamed M: The Univ. of Liverpool, UK
Pusztai L: MD Anderson Cancer Center, USA
Ross JS: Millennium Pharmaceuticals Inc., USA
Sadee W: Ohio State University, USA
|
